Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model

Abstract Background. Epidemiological studies suggest that, following infection with influenza virus, there is a short period during which a host experiences a lower susceptibility to infection with other influenza viruses. This viral interference appears to be independent of any antigenic similarities between the viruses. We used the ferret model of human influenza to systematically investigate viral interference. Methods. Ferrets were first infected then challenged 1–14 days later with pairs of influenza A(H1N1)pdm09, influenza A(H3N2), and influenza B viruses circulating in 2009 and 2010. Results. Viral interference was observed when the interval between initiation of primary infection and subsequent challenge was <1 week. This effect was virus specific and occurred between antigenically related and unrelated viruses. Coinfections occurred when 1 or 3 days separated infections. Ongoing shedding from the primary virus infection was associated with viral interference after the secondary challenge. Conclusions. The interval between infections and the sequential combination of viruses were important determinants of viral interference. The influenza viruses in this study appear to have an ordered hierarchy according to their ability to block or delay infection, which may contribute to the dominance of different viruses often seen in an influenza season.

[1]  Q. Jin,et al.  Influenza A/H1N1 2009 Pandemic and Respiratory Virus Infections, Beijing, 2009–2010 , 2012, PloS one.

[2]  Deborah Middleton,et al.  Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. , 2010, The Journal of infectious diseases.

[3]  A Linde,et al.  Does viral interference affect spread of influenza? , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[4]  T. Kuiken,et al.  Vaccination against Seasonal Influenza A/H3N2 Virus Reduces the Induction of Heterosubtypic Immunity against Influenza A/H5N1 Virus Infection in Ferrets , 2011, Journal of Virology.

[5]  C. Andrewes,et al.  Virus interference. I. The interferon , 2017 .

[6]  H. Kelly,et al.  Modelling the effect of seasonal influenza vaccination on the risk of pandemic influenza infection , 2011, BMC public health.

[7]  A. García-Sastre,et al.  Transmission of Pandemic H1N1 Influenza Virus and Impact of Prior Exposure to Seasonal Strains or Interferon Treatment , 2009, Journal of Virology.

[8]  N. Ferguson,et al.  Ecological and immunological determinants of influenza evolution , 2003, Nature.

[9]  R. Webster,et al.  Cross-Reactive, Cell-Mediated Immunity and Protection of Chickens from Lethal H5N1 Influenza Virus Infection in Hong Kong Poultry Markets , 2001, Journal of Virology.

[10]  Sebastian Maurer-Stroh,et al.  Antigenic Drift of the Pandemic 2009 A(H1N1) Influenza Virus in a Ferret Model , 2013, PLoS pathogens.

[11]  Bjoern Peters,et al.  Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population , 2009, Proceedings of the National Academy of Sciences.

[12]  A. Fontanet,et al.  Molecular monitoring of causative viruses in child acute respiratory infection in endemo-epidemic situations in Shanghai , 2010, Journal of Clinical Virology.

[13]  Laura C. Rosella,et al.  Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada , 2010, PLoS medicine.

[14]  Taeg S. Kim,et al.  Regulating the adaptive immune response to respiratory virus infection , 2012, Nature Reviews Immunology.

[15]  Cross-reactive human B cell and T cell epitopes between influenza A and B viruses , 2013, Virology Journal.

[16]  D. Pérez,et al.  Fitness of Pandemic H1N1 and Seasonal influenza A viruses during Co-infection , 2009, PLoS currents.

[17]  K. Taniguchi,et al.  Association between seasonal influenza vaccination in 2008-2009 and pandemic influenza A (H1N1) 2009 infection among school students from Kobe, Japan, April-June 2009. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  J. McVernon,et al.  The time-interval between infections and viral hierarchies are determinants of viral interference following influenza virus infection in a ferret model , 2016 .

[19]  A. Wanitchang,et al.  Inhibition of influenza A virus replication by influenza B virus nucleoprotein: an insight into interference between influenza A and B viruses. , 2012, Virology.

[20]  M. Yoshikawa,et al.  Isolation of influenza A/H3 and B viruses from an influenza patient: confirmation of co-infection by two influenza viruses. , 2006, Japanese journal of infectious diseases.

[21]  S. Nordbø,et al.  Virus interference. Did rhinoviruses activity hamper the progress of the 2009 influenza A (H1N1) pandemic in Norway? , 2011, Medical hypotheses.

[22]  B. Lina,et al.  Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1) 2009 virus in France. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[23]  A. Flahault,et al.  Dual infections by influenza A/H3N2 and B viruses and by influenza A/H3N2 and A/H1N1 viruses during winter 2007, Corsica Island, France. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[24]  Hans Nauwynck,et al.  Dual infections of feeder pigs with porcine reproductive and respiratory syndrome virus followed by porcine respiratory coronavirus or swine influenza virus: a clinical and virological study , 1996, Veterinary Microbiology.

[25]  I. Barr,et al.  MDCK-SIAT1 Cells Show Improved Isolation Rates for Recent Human Influenza Viruses Compared to Conventional MDCK Cells , 2008, Journal of Clinical Microbiology.

[26]  Nan Yan,et al.  Intrinsic antiviral immunity , 2012, Nature Immunology.

[27]  D. Skowronski,et al.  Seasonal Influenza Vaccine and Increased Risk of Pandemic A/H1N1-Related Illness: First Detection of the Association in British Columbia, Canada , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  T. Mazzulli,et al.  Characterization of an influenza A and influenza B co-infection of a patient in a long-term care facility with co-circulating influenza A and influenza B. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[29]  A. Nitsche,et al.  Do rhinoviruses reduce the probability of viral co-detection during acute respiratory tract infections? , 2009, Journal of Clinical Virology.

[30]  Y. Shimazu,et al.  [Eleven cases of co-infection with influenza type A and type B suspected by use of a rapid diagnostic kit and confirmed by RT-PCR and virus isolation]. , 2005, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[31]  W. Henle,et al.  INTERFERENCE OF INACTIVE VIRUS WITH THE PROPAGATION OF VIRUS OF INFLUENZA. , 1943, Science.

[32]  B. Cowling,et al.  Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  J. Lindenmann.  From interference to interferon: a brief historical introduction. , 1982, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[34]  Benjamin J. Cowling,et al.  The Age-Specific Cumulative Incidence of Infection with Pandemic Influenza H1N1 2009 Was Similar in Various Countries Prior to Vaccination , 2011, PloS one.

[35]  H. Kelly,et al.  Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[36]  Christopher T. McCaw,et al.  A Biological Model for Influenza Transmission: Pandemic Planning Implications of Asymptomatic Infection and Immunity , 2007, PloS one.

[37]  M. Pantin-Jackwood,et al.  Virus interference between H7N2 low pathogenic avian influenza virus and lentogenic Newcastle disease virus in experimental co-infections in chickens and turkeys , 2014, Veterinary Research.

[38]  M. Diamond,et al.  The broad-spectrum antiviral functions of IFIT and IFITM proteins , 2012, Nature Reviews Immunology.

[39]  J. Bloom,et al.  Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses , 2014, PLoS pathogens.

[40]  D. Pillai,et al.  Pandemic (H1N1) 2009 and seasonal influenza a (H1N1) co-infection, New Zealand, 2009 , 2010 .

[41]  I. Jaspers,et al.  Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures. , 2014, Vaccine.

[42]  B. Lina,et al.  Impact of the 2009 influenza A(H1N1) pandemic wave on the pattern of hibernal respiratory virus epidemics, France, 2009. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[43]  Gerhard Walzl,et al.  Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology , 2000, The Journal of experimental medicine.

[44]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[45]  L. Kasman,et al.  A systematic approach to virus–virus interactions , 2010, Virus Research.

[46]  Benjamin J Cowling,et al.  Virus interference and estimates of influenza vaccine effectiveness from test-negative studies. , 2012, Epidemiology.

[47]  A. Wanitchang,et al.  Nucleoprotein of influenza B virus binds to its type A counterpart and disrupts influenza A viral polymerase complex formation. , 2014, Biochemical and biophysical research communications.

[48]  E. Goldberg,et al.  Colinear synthesis of an antigen-specific B-cell epitope with a 'promiscuous' tetanus toxin T-cell epitope: a synthetic peptide immunocontraceptive. , 1997, Vaccine.